🧫
experiment

mTOR inhibition in mice ameliorated spheroid pathology, demonstrating therapeutic potential of targeting this pathway in vivo.

🧫 Experiment Protocol Animal ModelAlzheimer's diseaseMTORin_vivoextracted
In vivo mouse model with pharmacological mTOR inhibition
PRIMARY OUTCOME
mTOR inhibition in mice ameliorated spheroid pathology, demonstrating therapeutic potential of targeting this pathway in vivo.
LINKED HYPOTHESES
Source: pmid_40065072
🧫 Experiment Extras
PATHWAY
PI3K/AKT/mTOR pathway
MARKET PRICE
$0.50
STATUS
extracted
Related Target
MTORcomposite 0.419
View on SciDEX ↗